Item 1. Security and Issuer.
This Amendment No. 15 filed by Nutrien Ltd. (“Nutrien”) amends the Schedule 13D, dated November 2, 2001, as amended (the “Schedule 13D”), of Potash Corporation of Saskatchewan Inc. (“PCS”), a wholly owned subsidiary of Nutrien, and the affiliates of Nutrien listed in Item 2 with respect to Series A Shares of Sociedad Química y Minera de Chile S.A. (the “Issuer”), a company organized under the laws of the Republic of Chile. Effective January 1, 2018, PCS and Agrium, Inc. became wholly owned subsidiaries of Nutrien pursuant to a merger of equals transaction. The principal executive offices of the Issuer are located at El Trovador 4285, Santiago, Chile. Capitalized terms used but not otherwise defined in this Amendment No. 15 have the meanings ascribed to such terms in the Schedule 13D.
Item 2. Identity and Background.
This Amendment No. 15 is filed pursuant toRule 13d-2(a) under the Securities Exchange Act of 1934 (the “Exchange Act”) by the persons listed below (the “Reporting Persons”).
(1) Nutrien, a corporation organized under the laws of Canada, together with its direct and indirect subsidiaries, is the world’s largest provider of crop inputs and services, producing and marketing the three primary crop nutrients: potash, nitrogen and phosphate. Its principal business and office addresses are: Suite 500, 122 — 1st Avenue South, Saskatoon, Saskatchewan, Canada S7K 7G3 and 13131 Lake Fraser Drive S.E., Calgary, Alberta, Canada T2J 7E8.
(2) Inversiones PCS Chile Limitada (“PCS Chile”) is a limited liability company organized under the laws of the Republic of Chile principally for the purpose of acquiring and holding shares of the Issuer. Its principal business and office address is: Avenida Apoquindo 3721, Piso 12, comuna de Las Condes, Santiago, Chile. Nutrien beneficially owns the entire outstanding equity interest in PCS Chile.
(3) Inversiones El Boldo Limitada (“Chile Holdco”) is a limited liability company organized under the laws of the Republic of Chile principally for the purpose of acquiring and holding shares of the Issuer. Its principal business and office address is: Avenida Apoquindo 3721, Piso 12, comuna de Las Condes, Santiago, Chile. Nutrien beneficially owns the entire outstanding equity interest in Chile Holdco.
(4) Inversiones RAC Chile S.A. (“RAC”) is a closely held corporation organized under the laws of the Republic of Chile and was acquired by PCS principally for the purpose of acquiring and holding shares of the Issuer. Its principal business and office address is: Avenida Apoquindo 3721, Piso 12, comuna de Las Condes, Santiago, Chile. Nutrien beneficially owns the entire outstanding equity interest in RAC.
None of the Reporting Persons, during the last five years, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration.
Not applicable.
Item 4. Purpose of Transaction.
The information contained in Item 5(c) below is incorporated herein by reference.
Item 5. Interest in Securities of the Issuer.
(a)-(c) On December 5, 2018, the Reporting Persons sold (the “Sale”) 62,556,568 Series A Shares to Inversiones TLC SpA, a Chilean company by shares, and a wholly owned subsidiary of Tianqi Lithium Corporation, a corporation organized under the laws of the Peoples’ Republic of China. As a result of the Sale, the Reporting Persons no longer beneficially own any Series A Shares. The Sale was effected in an auction conducted on the Santiago Stock Exchange in a process known asremate martillero in compliance with Chilean law and the rules of the Santiago Stock Exchange. The purchase price was U.S.$65.00 per Series A Share, for aggregate gross proceeds to the Reporting Persons of U.S.$4.1 billion.